117 related articles for article (PubMed ID: 37173220)
21. Endometrial Carcinoma: Texture Analysis of Apparent Diffusion Coefficient Maps and Its Correlation with Histopathologic Findings and Prognosis.
Yamada I; Miyasaka N; Kobayashi D; Wakana K; Oshima N; Wakabayashi A; Sakamoto J; Saida Y; Tateishi U; Eishi Y
Radiol Imaging Cancer; 2019 Nov; 1(2):e190054. PubMed ID: 33778684
[TBL] [Abstract][Full Text] [Related]
22. Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance.
Brennan DJ; Hackethal A; Mann KP; Mutz-Dehbalaie I; Fiegl H; Marth C; Obermair A
BMC Cancer; 2015 Feb; 15():33. PubMed ID: 25655024
[TBL] [Abstract][Full Text] [Related]
23. Prediction of lymph node and distant metastasis in patients with endometrial carcinoma: a new model based on demographics, biochemical factors, and tumor histology.
Luomaranta A; Leminen A; Loukovaara M
Gynecol Oncol; 2013 Apr; 129(1):28-32. PubMed ID: 23333911
[TBL] [Abstract][Full Text] [Related]
24. Non-exenterative surgical management of recurrent endometrial carcinoma.
Moukarzel LA; Braxton KF; Zhou QC; Pedra Nobre S; Iasonos A; Alektiar KM; Tew WP; Abu-Rustum NR; Leitao MM; Chi DS; Mueller JJ
Gynecol Oncol; 2021 Aug; 162(2):268-276. PubMed ID: 34090704
[TBL] [Abstract][Full Text] [Related]
25. Risk-scoring models for individualized prediction of overall survival in low-grade and high-grade endometrial cancer.
AlHilli MM; Mariani A; Bakkum-Gamez JN; Dowdy SC; Weaver AL; Peethambaram PP; Keeney GL; Cliby WA; Podratz KC
Gynecol Oncol; 2014 Jun; 133(3):485-93. PubMed ID: 24690476
[TBL] [Abstract][Full Text] [Related]
26. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
[TBL] [Abstract][Full Text] [Related]
27. A novel preoperative scoring system based on 18-FDG PET-CT for predicting lymph node metastases in patients with high-risk endometrial cancer.
Aşıcıoğlu O; Gungorduk K; Ozdemir A; Güngördük Ö; Gokçü M; Yaşar L; Sancı M
J Obstet Gynaecol; 2019 Jan; 39(1):105-109. PubMed ID: 30187784
[TBL] [Abstract][Full Text] [Related]
28. Identification of prognostic factors and construction of a nomogram for patients with relapse/refractory adult-onset Still's disease.
Yin R; Wang G; Yang X; Zhang L; Wang S; Li T; Liu S
Clin Rheumatol; 2021 Oct; 40(10):3951-3960. PubMed ID: 34002352
[TBL] [Abstract][Full Text] [Related]
29. Significance of Monocyte Counts at Recurrence on Survival Outcome of Women With Endometrial Cancer.
Machida H; De Zoysa MY; Takiuchi T; Hom MS; Tierney KE; Matsuo K
Int J Gynecol Cancer; 2017 Feb; 27(2):302-310. PubMed ID: 27922978
[TBL] [Abstract][Full Text] [Related]
30. Treatment of advanced or recurrent endometrial carcinoma with doxorubicin in patients progressing after paclitaxel/carboplatin: Memorial Sloan-Kettering Cancer Center experience from 1995 to 2009.
Makker V; Hensley ML; Zhou Q; Iasonos A; Aghajanian CA
Int J Gynecol Cancer; 2013 Jun; 23(5):929-34. PubMed ID: 23598889
[TBL] [Abstract][Full Text] [Related]
31. Bone metastasis in primary endometrial carcinoma: features, outcomes, and predictors.
Yoon A; Choi CH; Kim TH; Choi JK; Park JY; Lee YY; Kim TJ; Lee JW; Bae DS; Kim BG
Int J Gynecol Cancer; 2014 Jan; 24(1):107-12. PubMed ID: 24343098
[TBL] [Abstract][Full Text] [Related]
32. Prediction of lymphatic dissemination in endometrioid endometrial cancer: Comparison of three risk-stratification models in a single-institution cohort.
Tuomi T; Pasanen A; Leminen A; Bützow R; Loukovaara M
Gynecol Oncol; 2017 Mar; 144(3):510-514. PubMed ID: 28069268
[TBL] [Abstract][Full Text] [Related]
33. Scoring system and a simple nomogram for predicting radioiodine refractory differentiated thyroid cancer: a retrospective study.
Liu Y; Wang Y; Zhang W
EJNMMI Res; 2022 Jul; 12(1):45. PubMed ID: 35904608
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant radiotherapy for stage I endometrial cancer.
Kong A; Johnson N; Kitchener HC; Lawrie TA
Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD003916. PubMed ID: 22513918
[TBL] [Abstract][Full Text] [Related]
35. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
Zhang Q; Xia T; Qi C; Du J; Ye C
BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
[TBL] [Abstract][Full Text] [Related]
36. Preoperative serum CA125: a useful marker for surgical management of endometrial cancer.
Jiang T; Huang L; Zhang S
BMC Cancer; 2015 May; 15():396. PubMed ID: 25964114
[TBL] [Abstract][Full Text] [Related]
37. The optimal cut-off value of immunohistochemical parameter P53 for predicting recurrence of endometrial cancer.
Jia M; Jiang P; Hu J; Huang Z; Deng Y; Hu Z
Int J Gynaecol Obstet; 2021 May; 153(2):344-350. PubMed ID: 33237570
[TBL] [Abstract][Full Text] [Related]
38. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
[TBL] [Abstract][Full Text] [Related]
39. RAM score is an effective predictor for early mortality and recurrence after hepatectomy for hepatocellular carcinoma.
Hsu HY; Yu MC; Lee CW; Tsai HI; Sung CM; Chen CW; Huang SW; Lin CY; Jeng WJ; Lee WC; Chen MF
BMC Cancer; 2017 Nov; 17(1):742. PubMed ID: 29121890
[TBL] [Abstract][Full Text] [Related]
40. A risk-scoring model for the prediction of endometrial cancer among symptomatic postmenopausal women with endometrial thickness > 4 mm.
Giannella L; Mfuta K; Setti T; Cerami LB; Bergamini E; Boselli F
Biomed Res Int; 2014; 2014():130569. PubMed ID: 24991535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
